Yang Lu, Sun Li, Cao Yalan, Wang Qi, Song Anni, Zhu Ru, Liu Wenqi, Lu Shengjun
Department of Pathogen Biology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China.
Department of Histology and Embryology, School of Basic Medicine, Guizhou Medical University, Guiyang, People's Republic of China.
J Inflamm Res. 2022 Jul 16;15:4027-4045. doi: 10.2147/JIR.S354224. eCollection 2022.
In schistosomiasis-associated hepatic fibrosis, the role of murine UL16-binding protein-like transcript 1 (MULT1), the strongest ligand of natural killer group 2-member D receptor (NKG2D), remains unclear. Here, -infected mice administered with MULT1-encoding DNA were used to test MULT1 as a potential therapy for schistosomiasis-associated hepatic fibrosis and explore relevant mechanisms.
A recombinant plasmid encoding MULT1 (p-rMULT1) was constructed and administered to -infected BALB/c mice via hydrodynamic tail vein injection. Egg granulomas in liver, hepatic fibrosis biomarkers and levels of cytokines were investigated. Comparisons of CD4+ T, CD8+ T, NK and NKT proportions as well as their phenotype were performed not only between infected, p-rMULT1 treated group and infected, backbone plasmid pEGFP-N1 treated group but also between infected, nontreated group and health control group.
Reduced area of granuloma formation and fibrosis around single eggs, downregulated expression of collagen I, α-smooth muscle actin, TGF-β and IL-10, and upregulated expression of IFN-γ, were observed in the livers of p-rMULT1 treated mice. p-rMULT1 treatment improved infection impacted immune microenvironment by modulating proportion of CD4 T CD8 T, natural killer (NK) and NKT cells, enhancing expression of NKG2D, in lymphocytes, and augmenting IFN-γ secretion by CD4 T, CD8 T, NK and NKT cells, as well as partially reversing some other phenotype changes of lymphocytes.
To the best of our knowledge, we provided the first in vivo evidence that MULT1 is a favorable anti-fibrosis factor in the context of schistosomiasis. The inhibitory effect of MULT1 overexpression on schistosomiasis associated with hepatic fibrosis may result from augmenting the proportion and function of NKG2D-expressing immune cells, and from enhancing NK- and T-cell activation, as well as regulating the helper T (Th)1/Th2 balance.
在血吸虫病相关肝纤维化中,小鼠UL16结合蛋白样转录物1(MULT1)作为自然杀伤细胞2型成员D受体(NKG2D)的最强配体,其作用仍不清楚。在此,利用感染了血吸虫的小鼠并给予编码MULT1的DNA,来测试MULT1作为血吸虫病相关肝纤维化潜在治疗方法的效果,并探索相关机制。
构建了编码MULT1的重组质粒(p-rMULT1),并通过尾静脉液压注射法将其给予感染了血吸虫的BALB/c小鼠。研究了肝脏中的虫卵肉芽肿、肝纤维化生物标志物及细胞因子水平。不仅比较了感染血吸虫、经p-rMULT1处理组与感染血吸虫、经空载体质粒pEGFP-N1处理组之间CD4⁺T、CD8⁺T、NK和NKT细胞比例及其表型,还比较了感染血吸虫、未处理组与健康对照组之间的上述指标。
在经p-rMULT1处理的小鼠肝脏中,观察到单个虫卵周围肉芽肿形成面积和纤维化程度降低,I型胶原蛋白、α平滑肌肌动蛋白、转化生长因子-β和白细胞介素-10的表达下调,以及干扰素-γ的表达上调。p-rMULT1处理通过调节CD4⁺T、CD8⁺T、自然杀伤(NK)和NKT细胞比例,增强淋巴细胞中NKG2D的表达,并增加CD4⁺T、CD8⁺T、NK和NKT细胞的干扰素-γ分泌,以及部分逆转淋巴细胞的其他一些表型变化,改善了血吸虫感染影响的免疫微环境。
据我们所知,我们首次在体内证明MULT1在血吸虫病背景下是一种有利的抗纤维化因子。MULT1过表达对血吸虫病相关肝纤维化的抑制作用可能源于增加表达NKG2D的免疫细胞的比例和功能,增强NK细胞和T细胞的活化,以及调节辅助性T(Th)1/Th2平衡。